RecruitingPHASE1, PHASE2NCT05804669
A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome
Studying ACTH-dependent Cushing syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Crinetics Pharmaceuticals Inc.
- Intervention
- atumelnant(drug)
- Enrollment
- 18 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (1)
- National Institutes of Health (NIH) - National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05804669 on ClinicalTrials.govOther trials for ACTH-dependent Cushing syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06635629Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing SyndromeNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- RECRUITINGNCT06962202Modified Desmopressin (mDesmo) Using Cold-Kit for PET/CTPost Graduate Institute of Medical Education and Research, Chandigarh